Concepedia

Tilman Schlothauer

TS

36

Publications

2.6K

Citations

25

H-Index

2003

Active since

Affiliations

Roche Pharma AG (Germany)(Current)

Roche (Switzerland)

University of Oslo

Oslo University Hospital

University of Copenhagen

Tilman Schlothauer is an author at Roche Pharma AG (Germany) specializing in antibody engineering, medicine, and immunology.

Top concepts

MedicineImmunologyAntibody EngineeringNatural SciencesBiochemistryCell BiologyBioanalysisImmunotherapyProteomicsSignal Transduction

Publications per year

2003–2024

36

Publications

36

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer, Sylvia Herter, Claudia Ferrara et al. · Protein Engineering Design and Selection · 2016 · 388 citations · Full text

Immunology, Immune Regulation, Immunodominance +24

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

Marco Thomann, Tilman Schlothauer, Tetyana Dashivets et al. · PLoS ONE · 2015 · 213 citations · Full text

Glycobiology, Immunology, Vitro Glycoengineering +23

MecA, an adaptor protein necessary for ClpC chaperone activity

Tilman Schlothauer, Axel Mogk, David A. Dougan et al. · Proceedings of the National Academy of Sciences · 2003 · 164 citations · Full text

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies

Markus Haberger, Katrin Bomans, Katharina Diepold et al. · mAbs · 2014 · 156 citations · Full text

Immunocytochemical Technique, Immunology, Glycobiology +20

Adaptor protein controlled oligomerization activates the AAA+ protein ClpC

Janine Kirstein, Tilman Schlothauer, David A. Dougan et al. · The EMBO Journal · 2006 · 146 citations · Full text

Protein Function, Protein Assembly, Natural Sciences +3

Rows per page

1–5 of 36